LTRN

Lantern Pharma Inc.

Health Care Quarter ended 2026-06-30 Filed 2026-08-14

A free key covers every company here: 1,000 calls a month, no card.

What it owns, and who has a claim on it

Both columns are the same height because they are the same money, counted twice: once by what it is, once by who it belongs to.

Owns$9M
Owed & owned$12M + -$3M
Assets, line by line
Cash$7M77%
Property & equipment$24K0%
Other assetsincludes 4 line items this filer does not report separately$2M22%
Liabilities and equity, line by line
Other liabilitiesincludes 2 line items this filer does not report separately$12M137%
Shareholders' equity-$3M37%

Not reported separately

This filer does not break these out. They are inside the totals, counted in the shaded remainder — not estimated, and not set to zero.

ReceivablesInventoryGoodwillIntangiblesAccounts payableLong-term debt
Liabilities exceed total assets, so equity is negative. It is drawn below the baseline.

Lantern Pharma Inc. (LTRN) files with the SEC as a health care company. Its most recent balance sheet puts total assets at $9M, against $12M of liabilities and -$3M of equity, as at 2026-06-30. That balance sheet grew 19.1% against 2026-03-31, when total assets were $7M. Liabilities account for 137.4% of the balance sheet and equity -37.4%. The largest single line on the asset side is Cash at $7M, 77.4% of total assets, followed by Property & equipment at $24,271. Equity is negative, so the claims against this company exceed what it owns on the filed figures. That is a real shape, not an error, and it is drawn below the baseline rather than hidden. The figures come from a filing filed on 2026-08-14. Some line items this filer reports are not broken out separately here; the totals are complete and the difference is shown as a remainder rather than distributed across the lines that are named. Assets equal liabilities plus equity on the filed figures, so this balance sheet reconciles directly. Every figure above is as filed, taken from the most recent filing that reported it. Nothing is estimated or smoothed, and where the filing and the identity disagree the disagreement is shown rather than closed.

Most of what LTRN owns is financial — cash and money owed to it account for 77% of total assets.

Liabilities exceed total assets, so shareholders' equity is negative at -$3.2 million.

Not every line item is reported separately by this filer: receivables, inventory, goodwill, intangibles and others are inside the totals rather than broken out.

The numbers behind Lantern Pharma Inc.’s balance sheet

The check, written out

Assets $8,602,349 − (liabilities $11,819,601 + equity -$3,217,252) = $0

Ratios

Ratios computed from this balance sheet
Liabilities to assets$12M ÷ $9M137.4%
Equity to assets-$3M ÷ $9M-37.4%
Largest asset line: Cash$7M ÷ $9M77.4%

Does it balance, quarter by quarter

8 of the last 8 tested balance sheets on file reconcile as this site reads them. Each row is judged by the same check as the drawing above, and “latest filing” is the newest filing that carried that period's figures, since later filings repeat earlier periods as comparatives.

Balance sheet totals and identity result by period
Period endLatest filingAssetsLiabilitiesEquityA = L + E
2026-06-302026-08-14$9M$12M-$3MBalanced
2026-03-312026-05-15$7M$4M$3MBalanced
2025-12-312026-03-30$11M$5M$7MBalanced
2025-09-302025-11-12$14M$4M$10MBalanced
2025-06-302025-08-13$17M$5M$13MBalanced
2025-03-312025-05-15$21M$4M$17MBalanced
2024-12-312025-03-27$26M$4M$21MBalanced
2024-09-302024-11-07$30M$4M$27MBalanced

Where to go from here

Ask about these numbers

Answered from the figures on this page and nothing else. Ask for something that is not here — another company, a share price, an earlier quarter — and it will tell you it is not in the filing data.

This is a language model reading the same numbers you can see. It does not predict, rate or recommend.

Learn more

Every figure here is also available as JSON — the API reference and what it costs.

Related companies

The nearest in size that file in the same sector, each drawn to the same scale.